RémyTrabelsi

Collaborateur

Paris + 33.1.56.59.46.62

Contact

Partager

Rémy Trabelsi exerce dans le domaine du droit des sociétés et des valeurs mobilières, en se concentrant sur les opérations réalisées sur les marchés de capitaux. Il conseille les émetteurs et les institutions financières sur un large éventail d'opérations complexes comme les introductions en bourse, les émissions de titres de capital ou de créances, les opérations de fusions et les offres publiques d'achat, ainsi que sur les obligations d'information périodique et permanente des émetteurs. Plus généralement, Rémy Trabelsi couvre l'ensemble des questions liées au droit des sociétés, y compris les sujets de gouvernance, et dispose d'une connaissance approfondie des réglementations européennes et françaises.

Depuis son arrivée chez Jones Day en 2021, Rémy Trabelsi a conseillé des émetteurs et des syndicats bancaires dans le cadre de diverses opérations impliquant des augmentations de capital (Nanobiotix, Forsee Power, Carbios, et Voltalia) ainsi que des introductions en bourse (Forsee Power, Waga Energy et Lhyfe). Il a également été impliqué dans la cotation d'EUROAPI (spin-off de Sanofi) et dans des opérations complexes de fusions ou d’acquisitions telles que des offres publiques d'achat (Europcar, NextStage SCA) ou encore le de-SPAC (special-purpose acquisition company) de Transition avec Arverne Group. En outre, Rémy Trabelsi conseille régulièrement des sociétés cotées en France sur leurs obligations d'information périodique et permanente et sur leurs problématiques ESG (environnementales, sociales et de gouvernance), avec un accent particulier sur les questions de gouvernance.

Avant de rejoindre Jones Day, Rémy Trabelsi a exercé au sein de cabinets d'avocats français et internationaux et a travaillé au sein du département juridique de sociétés cotées.

Expérience

  • Sanofi to separate its consumer healthcare business, OpellaJones Day is advising Sanofi in the separation of Opella, its consumer healthcare business, and the announced sale of a 50% controlling stake.
  • Valneva raises €61 million in accelerated bookbuilding offeringJones Day advised Valneva SE, a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs, in connection with its capital €61 million private placement through an accelerated bookbuilding process.
  • Tender offer for Eurobio Scientific launched by NextStage AM and IK PartnersJones Day is advising Eurobio Scientific SA in the tender offer launched by a consortium led by the management of Eurobio Scientific and funds managed by NextStage AM and IK Investment Partners, at a price of €25.3 per share increased by €1.25 per share if the threshold of 90% of Eurobio Scientific's capital and voting rights is reached, representing a maximum amount of approximately €161 million and valuating Eurobio Scientific at approximately €270 million.
  • Waga Energy raises €52 million in accelerated bookbuilding offeringJones Day advised Waga Energy, an independent producer of renewable biomethane (RNG) from landfill gas with operations in Europe and North America, on its €52 million accelerated bookbuilding private placement.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • BNP Paribas, Bryan Garnier, and Natixis complete €141 million capital increase of CarbiosJones Day advised BNP Paribas, Bryan Garnier, and Natixis in connection with the €141 million capital increase with shareholders' preferential subscription rights of Carbios, a biotech company specialized in the development and industrialization of biological technologies used for plastic and textiles recycling.
  • Forsee Power completes €50 million capital increaseJones Day advised Forsee Power, a French company listed on the regulated market of Euronext Paris which specializes in the design, manufacture, and marketing of intelligent battery systems for the electromobility market, in its capital increase without shareholders’ preferential subscription rights but with priority subscription period for an amount of approximately €50 million.
  • Voltalia completes €490 million capital increase with shareholders' preferential subscription rightsJones Day advised Voltalia S.A. in the €490 million capital increase with shareholders’ preferential subscription rights on the regulated market of Euronext in Paris.
  • NextStage Evergreen initiates alternative tender and exchange offer for NextStage sharesJones Day advised NextStage EverGreen and NextStage, a listed company specializing in development capital financing and support for medium-sized companies, in the context of the alternative takeover bid and exchange for the shares of NextStage SCA, initiated by NextStage Green, an unlisted company created for the purposes of the transaction.
  • Voltalia issues additional green bondsJones Day advised Voltalia in its offering of additional green bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs Vertes) due 2025 (the “New Bonds”) for a nominal amount of approximately €50 million (the “Offering”) fully fungible with the OCEANEs Vertes issued in January 2021 for a total nominal amount of approximately €200 million due on January 13, 2025, (the “Existing Bonds”).
  • Bank of America Europe acts as presenting bank of Volkswagen Group, Attestor Limited and Pon Holdings BV’s tender offer for and acquisition of Europcar MobilityJones Day advised Bank of America Europe acting as presenting bank in the €2.6 billion tender offer for and acquisition of Europcar Mobility Group launched by a consortium comprised of Volkswagen Group, Attestor Limited and Pon Holdings BV.
  • Bryan Garnier & Co Limited, Natixis, and Portzamparc complete up to €124 million IPO of Lhyfe on EuronextJones Day represented Bryan Garnier & Co Limited, Natixis, and Portzamparc (BNP Paribas Group), as joint lead managers and joint bookrunners, in connection with the up to €124 million initial public offering of Lhyfe on the regulated market of Euronext in Paris.
  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Forsee Power completes €115 million offering and IPO on regulated market of Euronext in ParisJones Day advised Forsee Power in connection with its initial public offering on the regulated market of Euronext in Paris and an offering of up to €115 million.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.